Nevertheless, although all of the primary AML samples we analyzed expressed the CALCRL and RAMP1 mRNAs and upregulated them in response to treatment with araC, the majority did not express either RAMP2 or RAMP3 [74]. This evidence concerns the gene RAMP2 and acute myeloid leukemia.